Cargando…

Comparison of the Effects of Carperitide and Tolvaptan on Patients with Left Ventricular Dysfunction: A Two-Center Retrospective Study

In patients with left ventricular (LV) dysfunction, diuretics can reduce blood pressure and lead to electrolyte abnormalities. The aim of this study was to compare the effects of tolvaptan (T group) and carperitide (C group) in these patients. Sixty-one consecutive patients admitted to the Iwate Pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koeda, Chikahiko, Yamaya, Shohei, Hozawa, Maiko, Sato, Masayuki, Nasu, Kazuhiro, Takahashi, Tomohiro, Terui, Katsutoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529620/ https://www.ncbi.nlm.nih.gov/pubmed/28785506 http://dx.doi.org/10.1155/2017/6935342

Ejemplares similares

Acute heart failure volume control multicenter randomized (AVCMA) trial: Comparison of tolvaptan and carperitide
por: Suzuki, Satoshi, et al.
Publicado: (2013)

Use of carperitide infusion for acutely decompensated heart failure
por: Morita, Yoshihisa, et al.
Publicado: (2012)

Possible Usefulness of Gadolinium-Enhanced Brain MRI for Evaluating Risk of Perioperative Hemorrhage: A Case of Infective Endocarditis
por: Koeda, Chikahiko, et al.
Publicado: (2014)

Effect of carperitide on the 1 year prognosis of patients with acute decompensated heart failure
por: Nogi, Kazutaka, et al.
Publicado: (2022)

Effects of early diuretic response to carperitide in acute decompensated heart failure treatment: A single-center retrospective study
por: Okuhara, Yoshitaka, et al.
Publicado: (2018)

Tolvaptan for the Treatment of Refractory Ascites
por: Kurosaki, Masayuki, et al.
Publicado: (2016)

Cardiovascular and renal effects of carperitide and nesiritide in cardiovascular surgery patients: a systematic review and meta-analysis
por: Mitaka, Chieko, et al.
Publicado: (2011)

Efficacy of tolvaptan for the patients with advanced hepatocellular carcinoma
por: Miyazaki, Masayuki, et al.
Publicado: (2017)

Impact of continued administration of tolvaptan on cirrhotic patients with ascites
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Tolvaptan
por: Rangarajan, Bharath, et al.
Publicado: (2014)

Effects of Carperitide on Contrast-Induced Acute Kidney Injury with a Minimum Volume of Contrast in Chronic Kidney Disease Patients
por: Okumura, Naoki, et al.
Publicado: (2012)

Association Between the Presence of Pulmonary Hypertension Before Cardiovascular Surgery and the Nephroprotective Effect of Carperitide: A Retrospective Cohort Study
por: Suzuki, Shin, et al.
Publicado: (2022)

Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use
por: Mizuno, Hiroki, et al.
Publicado: (2022)

A unique case of primary effusion lymphoma‐like lymphoma showing disappearance and recurrence of the body cavity effusion
por: Koeda, Chikahiko, et al.
Publicado: (2017)

Predictive factors for responders to tolvaptan in fluid management after cardiovascular surgery
por: Kido, Takashi, et al.
Publicado: (2016)

Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart Failure
por: Okada, Tomoaki, et al.
Publicado: (2023)

Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Left ventricular dysfunction in the newborn
por: Menahem, Samuel, et al.
Publicado: (2023)

Tolvaptan- and Tolvaptan-Metabolite-Responsive T Cells in Patients with Drug-Induced Liver Injury
por: Gibson, Andrew, et al.
Publicado: (2020)

The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2017)

Cases with Refractory Ascites and a Delayed Response to Tolvaptan
por: Hagiwara, Satoru, et al.
Publicado: (2016)

Successful Medical Treatment Using Tolvaptan of Ventricular Septal Rupture Following Myocardial Infarction
por: Terada, Kazushi, et al.
Publicado: (2017)

Tolvaptan for the Treatment of Enlarged Polycystic Liver Disease
por: Mizuno, Hiroki, et al.
Publicado: (2017)

Effects of omecamtiv mecarbil on the contractile properties of skinned porcine left atrial and ventricular muscles
por: Nakanishi, Tomohiro, et al.
Publicado: (2022)

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

Left ventricular dysfunction in the haemodialysis population
por: Sood, Manish M., et al.
Publicado: (2008)

Effects of door‐to‐tolvaptan time on short‐term clinical outcome in patients with acute heart failure
por: Nomura, Ryohei, et al.
Publicado: (2023)

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction
por: Matsue, Yuya, et al.
Publicado: (2017)

An Endomyocardial Biopsy of the Left Ventricle in an Anorexia Nervosa Patient with Sinus Bradycardia and Left Ventricular Systolic Dysfunction
por: Takahashi, Satoshi, et al.
Publicado: (2016)

Left Ventricular Diastolic Dysfunction Is Associated With the Prevalence of Paroxysmal Atrial Fibrillation Determined on the Latest Echocardiographic Criteria
por: Akima, Takashi, et al.
Publicado: (2020)

The impact of tissue-tracking strain on the left atrial dysfunction in the patients with left ventricular dysfunction
por: Koike, Hideki, et al.
Publicado: (2020)

Clinical features and long-term prognosis of patients with congestive heart failure taking tolvaptan: a comparison of patients with preserved and reduced left ventricular ejection fraction
por: Seki, Toshiki, et al.
Publicado: (2021)

Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKD
por: Higashihara, Eiji, et al.
Publicado: (2021)

Tolvaptan and its potential in the treatment of hyponatremia
por: Dixon, Megan B, et al.
Publicado: (2008)

V2 Receptor Antagonist; Tolvaptan
por: Yi, Joo-Hark, et al.
Publicado: (2011)

Predictors of the Effect of Tolvaptan on the Prognosis of Cirrhosis
por: Iwamoto, Takuya, et al.
Publicado: (2016)

The management of polycystic liver disease by tolvaptan
por: Takenaka, Tsuneo, et al.
Publicado: (2020)

Tolvaptan for the Treatment of Elephantiasis Nostras Verrucosa
por: Eda, Yuko, et al.
Publicado: (2019)

On myocardial siderosis and left ventricular dysfunction in hemochromatosis
por: Carpenter, John-Paul, et al.
Publicado: (2013)

Copeptin in Hemodialysis Patients with Left Ventricular Dysfunction
por: Kim, Jae Seok, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_r6ml8mslc21fc24shcdbmlcak2